Delivery Order SPE2DB22D1103-SPE2DB24FTMN3

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,177,676 units of the drug PREZCOBIX 800 MG-150 MG TABLET 30S. The $11,595.36 firm fixed-price contract has a completion date of July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, valued at $44,837.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is a firm fixed-price delivery order for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,923.02, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,167.54 firm fixed-price delivery order contract is for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $2,912.96 and a completion date of May 30, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,786.99 firm fixed-price delivery order is for PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,985.46, is for the delivery of PREZCOBIX 800 mg-150 mg tablets over a period ending on January 28, 2025. The contract has a firm fixed price pricing type and does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $17,044.17 firm fixed-price contract is for the supply of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product, with a period of performance through October 2, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,480.51 Firm Fixed Price Delivery Order contract is for the supply of the pharmaceutical product PREZCOBIX 800 MG-150 MG TABLET 30S. This contract does not have a set-aside designation, indicating open competition. The contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
This is a $57,504.07 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of PREZCOBIX 800 MG-150 MG TABLET 30S. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTMN3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,048.49, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product.

The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. The place of performance is Conshohocken, PA.

Generated 5/17/25, 10:04 AM